AAAndrea Aprilia

Andrea Aprilia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrea Aprilia has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anti-aging Effects of Angelica keiskei Leaf Extract on Skeletal Muscle: Associations with NF-κB p65 and PGC-1α in a D-galactose Model

    by Maria Dara Novi Handayani, Sultanto Rajasah, Rita Dewi, Ian Pranandi, Andrea Aprilia, Ferbian Milas Siswanto

    Aging-associated skeletal muscle dysfunction is highly interlinked to chronic inflammation and mitochondrial dysregulation, with the suppression of PGC-1α representing a key molecular event. The use of natural phytochemicals to prevent aging-related pathological conditions has received increasing attention, including Angelica keiskei . This study examined the effects of A. keiskei leaf extract on skeletal muscle in a D-galactose (D-gal)-induced aging rat model, focusing on NF-κB p65 protein levels and PGC-1α-associated mitochondrial regulatory markers. Male rats were administered D-gal to induce accelerated aging and subsequently treated with A. keiskei extract. NF-κB p65 levels were assessed by ELISA, while the mRNA expression of Ppargc1a and its target gene Tfam , and mitochondrial antioxidants ( Sod2 , Txn1 , and Prdx1 ) in skeletal muscle tissue was quantified using real-time quantitative PCR. Administration of D-gal markedly increased NF-κB p65 protein levels, reduced the Ppargc1a and Tfam expression, and inhibited the mRNA expression of Sod2 , Txn1 , and Prdx1 , suggesting that inflammation impairs mitochondrial biogenesis and antioxidant defenses. Treatment with A. keiskei extract reduced NF-κB p65 protein levels, restored Ppargc1a mRNA expression, and partially restored antioxidant-related gene expression. These data indicate that A. keiskei extract attenuates the molecular characteristics of skeletal muscle aging through the suppression of inflammaging and the preservation of the PGC-1α-dependent mitochondrial regulatory pathways. This study collectively provides preliminary preclinical evidence that A. keiskei leaf extract may attenuate selected molecular and functional features of D-gal-induced skeletal muscle aging through changes consistent with reduced inflammatory signaling and preservation of PGC-1α-associated mitochondrial regulation.

  • Open Access

    Correlation between Soluble Immunosenescence Biomarkers and Serum Neopterin Levels after COVID-19 Vaccination in a Geriatric Population

    by Kusworini Handono, Dominica Pita Sari, Hidayat Sujuti, Friska Supriyanto, Ferbian Milas Siswato, Akhmad Sabarudin, Andrea Aprilia

    The geriatric population is increasing worldwide, including in Indonesia which has reached 11.01% in 2021 as the leading country in the geriatric population in Southeast Asia. Consequently, there is an increased risk of having severe infection, malignancy, and autoimmunity. Aging of immunity (immunosenescence) is responsible not only for those conditions but also affects the immune response to vaccination. The study's purpose was to analyze the correlation between immunosenescence and a decreased cellular immune response between 6 and 24 weeks after the second dose of CoronaVac vaccination in the geriatric population. This was an observational analytical study with a prospective cohort design. 73 geriatric subjects (≥ 60 years old) who had already received a second dose of CoronaVac were included. All the subjects had blood taken at 6 and 24 weeks after the second dose of CoronaVac. Serum sCD28, sCD80, and sCTLA-4 were used as immunosenescence markers. The decrease in cellular immunity was measured by the decreasing level of serum neopterin between 6 and 24 weeks following vaccine administration. There is a moderate correlation between sCD28, sCD80, and sCTLA-4 with serum neopterin at weeks 6 and 24. We also found a significant correlation between the decrease in neopterin at 6 and 24 weeks with sCD80 (p = 0.016, r = 0.282) but not with sCD28 (p = 0.078, r = 0.207) or sCTLA-4 (p = 0.017, r = 0.279). sCD80 and sCTLA-4 correlated with a more rapid decrease in neopterin level after CoronaVac vaccination in the geriatric population.

  • Open Access

    Prognostic utility of combined suPAR and procalcitonin levels for mortality prediction in sepsis patients

    by Agustin Iskandar, Aryati, Wiwi Jaya, Andrea Aprilia, Salvatore Di Somma

  • Open Access

    Macrophage Migration Inhibitory Factor as a Biomarker of Severe Dengue and Shock in Children: A Cross-Sectional Study in Indonesia

    by Agustin Iskandar, Iswanto Korompot, Andrea Aprilia, Irene Ratri Dewi

    Dengue remains a leading cause of child mortality in Indonesia. Identifying reliable biomarkers to predict disease severity is essential for early intervention. Macrophage Migration Inhibitory Factor (MIF) is a pro-inflammatory cytokine involved in the pathogenesis of dengue. This study aimed to assess the relationship between MIF levels and dengue severity in children, and to compare the predictive value of MIF levels with C-Reactive Protein (CRP) and serum albumin levels. A cross-sectional study was conducted on 104 pediatric dengue patients hospitalized at Saiful Anwar General Hospital. Serum levels of MIF (ELISA), CRP, and albumin were measured upon admission. Patients were categorized into four severity grades (Grade 1–4) and also stratified into shock and non-shock groups. Statistical analyses included ANOVA, correlation analysis, and receiver operating characteristic (ROC) curve evaluation. MIF levels showed a significant stepwise increase with disease severity and were significantly higher in patients with shock (p < 0.001). CRP levels were also elevated in severe dengue, but the correlation with severity was moderate (r = 0.61, p < 0.05). In contrast, serum albumin levels were inversely associated with severity (r = –0.67, p < 0.05), with lower values observed in the shock group. ROC analysis demonstrated that MIF had the highest predictive accuracy for shock (AUC = 0.94), compared to CRP (AUC = 0.78) and albumin (AUC = 0.81). MIF is a robust biomarker for predicting dengue severity and shock in children, outperforming CRP and albumin in diagnostic performance. The integration of MIF with conventional markers may improve early risk stratification and clinical decision-making in pediatric dengue.

  • Open Access

    EFEKTIVITAS EDUKASI TALASEMIA BERBASIS VIDEO: SUATU SURVEI DAN SKRINING PADA POPULASI AKADEMIS

    by Ita M. Nainggolan, Dhea Agatha Andrian, Sheella Rima Bororing, Andrea Aprilia

    Talasemia adalah kelainan darah genetik yang belum dapat disembuhkan dan pengobatan kuratif masih mahal, sulit, serta banyak efek samping. Pengobatan suportif yang diberikan menyebabkan beban ekonomi semakin besar karena kasus talasemia semakin meningkat. Pencegahan berupa deteksi dini pembawa sifat talasemia merupakan upaya yang sangat penting untuk dilakukan. Edukasi merupakan metode yang dapat digunakan untuk meningkatkan kesadaran masyarakat sehingga berminat untuk melakukan deteksi dini. Video adalah salah satu media yang sering digunakan untuk mempermudah penyampaian informasi. Keberhasilan edukasi dapat diukur melalui survei berupa tes sebelum dan sesudah video edukasi diberikan. Tujuan kegiatan pengabdian masyarakat ini adalah untuk mengetahui pengaruh edukasi talasemia menggunakan intervensi video terhadap perubahan pengetahuan dan sikap awareness seseorang terhadap talasemia yang diikuti dengan keikutsertaan dalam skrining talasemia. Sebanyak sepuluh soal pre-test dan post-test pengetahuan talasemia dan satu soal awareness talasemia diberikan kepada 96 peserta dari civitas academica Universitas Timika, Politeknik Amamapare, dan Poltekkes Kemenkes Jayapura Kampus Timika dengan intervensi video edukasi berdurasi sekitar enam menit. Hasilnya terjadi peningkatan pengetahuan sebanyak 31% antara pre-test dan post-test (p<0,001) serta 69% perubahan sikap awareness yang ditandai dengan kesediaan mengikuti skrining talasemia. Kesimpulannya adalah terdapat pengaruh positif dari penggunaan video edukasi sebagai intervensi dalam survei pengetahuan dan sikap untuk deteksi dini talasemia.

  • Open Access

    Diagnostic Performance of IL-1β and C-Reactive Protein in Childhood Tuberculosis

    by Agustin Iskandar, Desyi Halim, Hani Susianti, Ery Olivianto, Andrea Aprilia

    Interleukin (IL)-1β, a proinflammatory cytokine produced by phagocytes infected with Mycobacterium tuberculosis, is known for its stability in storage, which ensures consistent measurement in clinical settings. This stability, along with its unaffected levels by age, sex, or lung disease severity, makes IL-1β a promising biomarker in tuberculosis (TB). This study aims to evaluate the diagnostic performance of IL-1β and C-reactive protein (CRP) in childhood TB. cross-sectional study was conducted on 77 children with suspected TB at Saiful Anwar Hospital. The inclusion criteria were based on the 2016 technical guidelines for TB. IL-1β levels were measured using Elisa, while CRP was assessed via immunoturbidimetry. A significant difference in mean IL-1β levels was observed between the TB and non-TB groups (p = 0.028). However, IL-1β showed a weak correlation with the TB group (r = 0.251, p = 0.027). The area under the curve (AUC) for IL-1β was 0.671 (p = 0.028) with 52.5% sensitivity, 83.3% specificity, 91.1% positive predictive value (PPV), 34.8% negative predictive value (NPV), and 59.7% accuracy at a cut-off of 6.1 pg/mL. CRP levels showed no significant correlation or difference between the groups. The combination of IL-1β and CRP yielded an AUC of 0.669 (p = 0.031), with 41.5% sensitivity, 75% specificity, 84.4% PPV, 28.1% NPV, and 49.3% accuracy. Although IL-1β shows moderate diagnostic performance and CRP alone or combined with IL-1β has limited utility in diagnosing childhood TB, IL-1β still holds potential as a biomarker. Its high positive predictive value (PPV) indicates strong reliability in confirming TB, making it a valuable tool in a broader diagnostic or monitoring of childhood TB.

  • Open Access

    Development of Nuclear Antigen for Detection of Anti-Nuclear and Anti-DFS70 Antibodies in Systemic Lupus Erythematosus Patients

    by Kusworini Handono, Hani Susianti, Syahrul Chilmi, Andrea Aprilia, Rahmatul Yasiro, Natalia Sukarta

    Systemic Lupus Erythematosus (SLE) is a medical condition characterized by an abnormal immune response that affects multiple organs and tissues, resulting in a range of symptoms and potential problems. To confirm or exclude a diagnosis of systemic lupus erythematosus (SLE), it is necessary to conduct tests for anti-nuclear antibody (ANA) and anti-DFS70 antibody. The most widely accepted and reliable approach for detecting antinuclear antibodies (ANA) is the indirect immunofluorescent test (IIFA), which is known for its complexity and high cost. Therefore, it is imperative to create a more cost-effective and simplified test for the detection of ANA and anti-DFS70 antibodies. Our preliminary study aimed to isolate sensitive and specific antigens for the detection of ANA and anti-DFS70 antibodies using the dot blot method. Nuclear antigens were isolated from leukocytes of SLE patients who underwent leukapheresis. DSF70 antigens were obtained from R&D Systems (RH-LEDGF cat.no 3468-LE, Lot: ODX0819071). Nuclear antigens and DFS70 antigen were attached to the nitrocellulose membrane dot blot with a dilution of 0.01 mcg/mL and 0.1 mcg/mL, respectively. Furthermore, the antigens were tested for sensitivity and specificity in 56 SLE patients and 34 healthy controls. As a comparison for ANA and anti-DFS70 antibody tests, the ELISA methods were used. The sensitivity and specificity of dot blot methods using the nuclear antigen were 61.5% and 84.6% and the DSF70 antigen were 45.5% and 82.3%, respectively. There were moderate sensitivity and good specificity dot blot methods using both nuclear and DFS-70 antigens for ANA and anti-DFS70 antibody detection. The method of nuclear antigen preparation still needs to be modified to improve its sensitivity.

  • Open Access

    Analysis of TNF-like weak inducer of apoptosis for detecting lupus nephritis

    by Hani Susianti, Dian Sukma Hanggara, Kristina Dyah Lestari, Putri Purnamasari, Andrea Aprilia

    Lupus is an autoimmune disease that has various manifestations in various organs. One of the manifestations of lupus is lupus nephritis (LN), which often causes kidney failure and death. Cytokines play an essential role in the pathogenesis of LN and might be helpful for LN biomarkers. This study aimed to evaluate urine TNF-like weak inducer of apoptosis (TWEAK) for detecting LN since this is not an invasive procedure and is more cost-effective. The gold standard procedure for diagnosing LN needs a biopsy of the kidney. However, the procedure is invasive, high cost, and takes time. Thus, a biomarker from urine is needed for early diagnosis of LN. This research conducted was cross-sectional. The total participants were 57, consisting of 29 lupus nephritis and 28 lupus without nephritis. TWEAK levels were determined by ELISA method; urine protein, urine erythrocyte, and leukocyte were examined by a urine autoanalyzer. Statistical analysis using Mann–Whitney, Spearman correlation, Kruskal–Wallis, ROC curve analysis, and a 2 × 2 contingency table. This study showed a significant difference in TWEAK levels between lupus nephritis and lupus without nephritis (p < 0.05), but no significant difference between TWEAK level and renal domain scores of SLEDAI. There were significant correlations between TWEAK level and urine erythrocyte and urine protein, but there was no significant correlation with urine leukocytes. The sensitivity and specificity of TWEAK for determining LN were 72.4% and 72.5%, respectively, with AUC 0.77. TWEAK had a good diagnostic test for detecting lupus nephritis and substantially correlated with urine erythrocyte and urine protein.


  • Open Access

    The profile of lactate, albumin, and lactate/albumin ratio as predictors of mortality in sepsis patients

    by A. Iskandar, M. I. Vincentia, W. Jaya, A. Aryati, A. Pramadhani, A. Aprilia, В. Джая

    Background. Oxygenation disturbances in sepsis patients may cause lactate levels increase which is proportional to the severity of the inflammation, followed by decrease in albumin levels. Combination of these two parameters is expected to be predictor of mortality in patients with sepsis. The aim of this study is to investigate the profile of lactate, albumin, and lactate/albumin ratio as mortality predictors in patient with sepsis. Methods. This prospective cohort study was conducted in the ICU of dr. Saiful Anwar Hospital, Malang, from January to May 2019. Subjects were 82 patients with sepsis (SOFA score 2). Lactate and albumin levels were measured on the first day of hospitalization. Lactate levels were examined by colorimetric method, albumin was examined by BCG method. The instrument used was Cobas 501. Comparation was carried out using the T-Test/Mann–Whitney test. Prediction of mortality risk was done using relative risk (RR) determination. Results. Significant difference was observed in albumin levels between sepsis patients who survived and who died (p = 0.045). No significant differences were observed in lactate levels and lactate/albumin ratio between sepsis patients who survived and who died (p = 0.211, 0.119, respectively). Relative risks were 3.034 for lactate, 3.667 for albumin, and 4.400 for lactate/albumin ratio. Conclusion. In patients with sepsis, albumin level is the best variable in predicting mortality, followed by lactate/albumin ratio and lactate value. Further study that implements repeated measurement of lactate and albumin in 6 and 12 hours is required to better predict the mortality of sepsis patients.